The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krasnopol'skaia I.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Popov A.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Gorina N.V.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia

Kareva E.N.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia

Balan V.E.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Gene expression of collagen metabolic proteins in the paraurethral connective tissue of women with urinary incontinence and small pelvic organ prolapse

Authors:

Krasnopol'skaia I.V., Popov A.A., Gorina N.V., Kareva E.N., Balan V.E.

More about the authors

Read: 2456 times


To cite this article:

Krasnopol'skaia IV, Popov AA, Gorina NV, Kareva EN, Balan VE. Gene expression of collagen metabolic proteins in the paraurethral connective tissue of women with urinary incontinence and small pelvic organ prolapse. Russian Bulletin of Obstetrician-Gynecologist. 2015;15(6):36‑41. (In Russ.)
https://doi.org/10.17116/rosakush201515636-41

Recommended articles:

References:

  1. Al’-Shukri S.Kh., Kuz’min I.V. Symptoms, clinical course and treatment of the female vesical hyperactivity. Ginekologiya. 2008;10:4:78-80. (In Russ.).
  2. Alyaev Yu.G., Grigoryan V.A., Gadzhieva Z.K. Rasstroistva mocheispuskaniya. [Disturbances of urination]. Moscow: Litterra. 2006;208. (In Russ.).
  3. Loran O.B., Seregin A.V., Sinyakova L.A., Seregin A.A. Sovremennye metody lecheniya nederzhaniya mochi i prolapsa organov malogo taza. [Modern trends in treatment of urinary incontinence and small pelvic organ prolapse]. 2006. http://intim-surgery.com.ua/2010/01/17/sovremennye-metody-lecheniya-nederzhaniya-mochi-i-prolapsa-organov-malogo-taza/. (In Russ.).
  4. Nechiporenko N. Fomale urine incontinance: new approaches to treatment. Meditsinskii vestnik. 2007;44:25. (In Russ.).
  5. Dobrokhotova Yu.E., Il’ina I.Yu., Zhdanova M.S. Influence of connective tissue dysplasia on genital prolapse. Rossiiskii vestnik akushera-ginekologa. 2009;4:15-18. (In Russ.).
  6. Mekhedko V.V., Moshkovskii A.N. Genital prolapse: etiology, pathogenesis, clinical course. Zhinochii likar. 2009;1:26. (In Russ.).
  7. Karymova E.I. Prevention of postoperative infectious complications in perimenopausal women in the surgical correction of internal genital descent and prolapse. Rossiiskii vestnik akushera-ginekologa. 2007;7:6:20-27. (In Russ.).
  8. Malichenko S.B., Volkova V.A., Khalidova K.K. Systemic changes in climacteric: role of calcium deficit and vitamin D in forming postmenopausal symptoms. Consilium medicum. 2007;12:9-18. (In Russ.).
  9. Martin JL, Williams KS, Abrams KR. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technology Assessment. 2006;10:6.
  10. Martin JL, Williams KS, Sutton AJ. Systematic review and meta-analysis of methods of diagnostic assessment for urinary incontinence. Neurourology and Urodynamics. 2006;25:674-683.
  11. Makowsky GS, Ramsby ML. Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids. Clinical & Experimental Immunology. 2004;136:1:176-187.
  12. Botasheva D.A., Adamyan L.V., Danilov A.Yu. Geneticheskie i fermentativnye markery prolapsa genitalii. [Genetic and fermentative markers of the genital prolapse]. Ed. Sukhikh G.T., Adamyan L.V. Moscow: MEDI Ekspo. 2010;304. (In Russ.).
  13. Ignat’eva N. Collagen is the main protein of the connective tissue. Esteticheskaya meditsina. 2005;4:3:246-256. (In Russ.).
  14. Kapitonova M.Yu., Samusev R.P., Kuznetsov S.L. Obshchaya i chastnaya gistologiya. [Common and particular histology]. ONIKS: Mir i Obrazovanie. 2010;336. (In Russ.).
  15. Severin E.S. Biokhimiya. [Biochemistry]. Moscow: GEOTAR-Media. 2009;768 (In Russ.).
  16. Banos C, Thomas A, and Kuo C. Collagen fibrillogenesis in tendon development: current models and regulation of fibril assembly. Birth Defects Research (Part C). 2008;84:228-244.
  17. Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Current Opition in Cell Biology. 2008;20:5-24:495-501.
  18. Song Y, Hong X, Yu Y. Changes of collagen type III and decorin in paraurethral connective tissue from women with stress urinary incontinence and prolapse. International Urogynecology Journal. 2007;18:1459-1463.
  19. Balducci C, Lilli C, Stabellini G. Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene. BioMed Central Cancer. 2005;5:22.
  20. Davidson RK, Waters JG, Kevorkian L. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Research & Therapy. 2006;8:4:R124.
  21. Elkington PTG, O’Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clinical & Experimental Immunology. 2005;142:1:12-20.
  22. Leonardo C, Eakin A, Ajmo J, Collier L. Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat. Journal of  Neuroinflammation. 2008;5:34.
  23. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. The Journal of  Clinical Investigation. 1999;103:9:237-1241.
  24. Yen J-H, Khayrullina T, Ganea D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood. 2008;111:1:260-270.
  25. Zong W, Meyn LA, Moalli PA. The Amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. 2009;80:2:367-374.
  26. Ameye L, Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Oxford Journals Life/Sciences & Medicine/Glycobiology. 2002;12:Issue 9:107R-116R.
  27. Trabucco E, Soderberg M, Cobellis L. Role of proteoglycans in the organization of periurethral connective tissue in women with stress urinary incontinence. Maturitas The European Menopause Journal. 2007;58:395-405. 
  28. Wen YY, Zhao Y, Li,S. Differences in mRNA and protein expression of small proteoglycans in vaginal wall tissue from women with and without stress urinary incontinence. Human Reproduction. 2007;22:6:1718-1724.
  29. Balan V.E., Kovaleva L.A. Climacteric urogenital disturbances: option of hormonal therapy. Ginekologiya. 2009;11:6:23-25 (In Russ.).
  30. Shestakova I.G. Replacement hormonotherapy in climacterium: modern trends. Ginekologiya. 2009;11:2:19-22. (In Russ.).
  31. Shestakova I.G. Possibilities of replacement hormonotherapy in gynecologic practice. Ginekologiya. 2010;12:1:10-13. (In Russ.).
  32. Connell AK, Guess MK, Chen H. HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. The Journal of Clinical Investigation. 2008;118:3:1050-1055.
  33. http://nmus.net/load/patologicheskaja_anatomija/lekcii/glava_8_kompensatorno_ prisposobitelnye_processy/69-1-0-642

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.